Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

July 31, 2012

Conditions
InfluenzaAvian Influenza
Interventions
BIOLOGICAL

LAIV H7N3

2 doses of vaccine

BIOLOGICAL

placebo

2 doses of placebo

Trial Locations (1)

197376

Research Institute of Influenza, Saint Petersburg

All Listed Sponsors
collaborator

Ministry of Health, Russian Federation

OTHER_GOV

collaborator

Research Institute of Influenza, Russia

OTHER

collaborator

Institute of Experimental Medicine, Russia

OTHER

lead

PATH

OTHER

NCT01511419 - Safety Trial of Live Attenuated Influenza (H7N3) Vaccine | Biotech Hunter | Biotech Hunter